Trial to evaluate SYN-004 for C. difficile, antibiotic-associated diarrhea … – Healio


Smarter Analyst
Trial to evaluate SYN-004 for C. difficile, antibiotic-associated diarrhea
Healio
A phase 2b proof-of-concept clinical trial has been initiated to evaluate the efficacy of SYN-004 for preventing Clostridium difficile infection, and C. difficile- and antibiotic-associated diarrhea among hospitalized patients with lower respiratory
Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical TrialMarketWatch
Biotech Stocks Leaving Investors Heartbroken – Vascular Biogenics Ltd (NASDAQ Wall Street Observer

all 21 news articles »

diarrhea – Google News